An up-to-date review on ashwagandha clinical research studies with Chris Kilham - video
There is value in conducting multiple studies related to the same ingredient for the specified health conditions. Chris Kilham, a.k.a. “The Medicine Hunter” spoke with us at SupplySide West 2018 about four studies pending publication related to KSM-66 ashwagandha, and the process that drives credible publication.
December 2, 2018
Sponsored by KSM-66
Conducting clinical studies on an ingredient is a rigorous process that requires more than correct modeling, observable and measurable outcomes. Credible studies require exhaustive peer review prior to publication, a process that bears no relationship to commercial outcomes. Join us as Chris Kilham provides an early view at condition specific clinical studies on ashwagandha pending publication.
You May Also Like